Carrera Capital Advisors Purchases 1,434 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Carrera Capital Advisors boosted its position in DocuSign, Inc. (NASDAQ:DOCU) by 13.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 12,165 shares of the company’s stock after buying an additional 1,434 shares during the quarter. Carrera Capital Advisors’ holdings in DocuSign were worth $1,094,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DOCU. Toronto Dominion Bank grew its position in shares of DocuSign by 30.3% in the 3rd quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after buying an additional 6,081 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after acquiring an additional 16,014 shares in the last quarter. Quantinno Capital Management LP grew its holdings in DocuSign by 39.5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after purchasing an additional 57,104 shares during the period. Robeco Institutional Asset Management B.V. increased its stake in shares of DocuSign by 7.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock valued at $80,501,000 after purchasing an additional 85,987 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in shares of DocuSign by 118.8% during the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after purchasing an additional 330,136 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Insiders Place Their Bets

In related news, insider Robert Chatwani sold 14,800 shares of the firm’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the transaction, the insider now owns 73,414 shares of the company’s stock, valued at approximately $7,176,952.64. This trade represents a 16.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares of the company’s stock, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 686,010 shares of company stock valued at $66,102,694. Company insiders own 1.66% of the company’s stock.

DocuSign Stock Up 0.4 %

Shares of DOCU stock opened at $82.06 on Wednesday. The firm has a market capitalization of $16.58 billion, a PE ratio of 16.92, a P/E/G ratio of 6.94 and a beta of 0.89. The company has a 50 day moving average price of $89.89 and a 200-day moving average price of $78.25. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on DOCU shares. Jefferies Financial Group upped their price target on DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company raised their price target on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a research report on Tuesday, February 4th. Piper Sandler increased their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Finally, Morgan Stanley lifted their target price on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a report on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.